### 2.2.1 In vitro / physicochemical data

A literature search was performed to collect available information on physicochemical properties of amikacin. The obtained information from literature is summarized in the table below, and is used for model building.

| **Parameter**   | **Unit** | **Value (reference)**                            | **Description**                        |
| :-------------- | -------- | ------------------------------------------------ | -------------------------------------- |
| MW              | g/mol    | 588.6 ([Claassen 2015](#5-references))           | Molecular weight                       |
| pKa             |          | 9.7, 8.92, 8.13 ([Claassen 2015](#5-references)) | Acid dissociation constants            |
| Solubility (pH) | mg/L     | 50 (7)  ([Drugbank.ca](#5-references))           | Solubility                             |
| logMA           |          | -0.48 ([Claassen 2015](#5-references))           | The logarithm of the membrane affinity |
| fu              |          | 1 ([Claassen 2015](#5-references))               | Fraction unbound                       |
| GFR fraction    |          | 1 ([Claassen 2015](#5-references))               | Glomerular Filtration Rate fraction    |

### 2.2.2 Clinical data

A literature search was performed to collect available clinical data on amikacin in adults. 

The following publication was found in adults for the evaluation of the reported amikacin PBPK model:

| Publication                       | Study description                                            |
| :-------------------------------- | :----------------------------------------------------------- |
| [Walker 1979](#5-references) | The pharmacokinetics of amikacin and gentamicin in healthy volunteers |

